ALKS
insider transactionsAlkermes plc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-156.5K
0 buy · 156.5K sell
Net value · 365d
-$5.5M
$0 in · $5.5M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
19
0 buy · 156.5K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Director · 10b5-1
$90.2K
2.0K sh · $45.10
Own -7%
-
Sell·S
EVP, CLO, Alkermes, Inc. · 10b5-1
$87.6K
2.0K sh · $43.05
Own -1%
-
Exercise·M
EVP R&D, Chief Medical Officer · 10b5-1
$0
5.0K sh
Own +369%
-
Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$375.0K
9.0K sh · $41.67
Own -10%
-
Exercise·M
EVP R&D, Chief Medical Officer · 10b5-1
$96.7K
5.0K sh · $19.34
Own +6%
-
Exercise·M
VP, Finance (Interim PAO)
$0
12.8K sh
Own +1282500%
-
Exercise·M
VP, Finance (Interim PAO)
$0
3.4K sh
Own +169600%
-
Sell·S
VP, Finance (Interim PAO)
$687.0K
16.2K sh · $42.36
Own -68%
-
Exercise·M
VP, Finance (Interim PAO)
$248.0K
12.8K sh · $19.34
Own +115%
-
Exercise·M
VP, Finance (Interim PAO)
$67.9K
3.4K sh · $20.03
Own +44%
-
Exercise·M
Director
—
6.1K sh
Own New
-
Other·F
Director
$54.5K
1.5K sh · $36.95
Own -5%
-
Exercise·M
Director
—
6.1K sh
Own +27%
-
Exercise·M
Director
—
6.1K sh
Own New
-
Other·F
Director
$54.5K
1.5K sh · $36.95
Own -4%
-
Exercise·M
Director
—
6.1K sh
Own +20%
-
Exercise·M
Director
—
6.1K sh
Own New
-
Other·F
Director
$54.5K
1.5K sh · $36.95
Own -9%
-
Exercise·M
Director
—
6.1K sh
Own +57%
-
Exercise·M
Director
—
6.1K sh
Own New
-
Other·F
Director
$54.5K
1.5K sh · $36.95
Own -4%
-
Exercise·M
Director
—
6.1K sh
Own +18%
-
Exercise·M
Director
—
6.1K sh
Own New
-
Other·F
Director
$54.5K
1.5K sh · $36.95
Own -7%
-
Exercise·M
Director
—
6.1K sh
Own +45%
-
Exercise·M
Director
—
6.1K sh
Own New
-
Other·F
Director
$54.5K
1.5K sh · $36.95
Own -4%
-
Exercise·M
Director
—
6.1K sh
Own +21%
-
Exercise·M
Director
—
6.1K sh
Own New
-
Other·F
Director
$54.5K
1.5K sh · $36.95
Own -4%
-
Exercise·M
Director
—
6.1K sh
Own +20%
-
Exercise·M
Director
—
6.1K sh
Own New
-
Other·F
Director
$118.5K
3.2K sh · $36.95
Own -3%
-
Exercise·M
Director
—
6.1K sh
Own +6%
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
11.5K sh
Own New
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
11.5K sh
Own New
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
11.5K sh
Own New
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
11.5K sh
Own New
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
11.5K sh
Own New
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
11.5K sh
Own New
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
11.5K sh
Own New
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
11.5K sh
Own New
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
11.5K sh
Own New
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
11.5K sh
Own New
-
Sell·S
EVP, CLO, Alkermes, Inc. · 10b5-1
$67.5K
2.0K sh · $33.20
Own -1%
-
Exercise·M
EVP R&D, Chief Medical Officer · 10b5-1
$0
5.0K sh
Own +79%
-
Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$300.6K
9.0K sh · $33.40
Own -10%
-
Exercise·M
EVP R&D, Chief Medical Officer · 10b5-1
$96.7K
5.0K sh · $19.34
Own +6%
-
Exercise·M
Director
—
3.8K sh
Own +375100%
-
Other·F
Director
$30.1K
901 sh · $33.36
Own -6%
-
Exercise·M
Director
—
3.8K sh
Own +35%
-
Sell·S
EVP, CLO, Alkermes, Inc. · 10b5-1
$70.3K
2.0K sh · $34.57
Own -1%
-
Exercise·M
EVP R&D, Chief Medical Officer · 10b5-1
$0
5.0K sh
Own +44%
-
Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$319.6K
9.0K sh · $35.51
Own -10%
-
Exercise·M
EVP R&D, Chief Medical Officer · 10b5-1
$96.7K
5.0K sh · $19.34
Own +6%
-
Sell·S
EVP, CLO, Alkermes, Inc. · 10b5-1
$60.5K
2.0K sh · $29.76
Own -1%
-
Grant·A
Joshua Reed KEY
SVP, Chief Financial Officer
$0
30.9K sh
Own New
-
Grant·A
Joshua Reed KEY
SVP, Chief Financial Officer
$0
66.4K sh
Own New
-
Grant·A
POPS RICHARD F KEY
Director and CEO, Alkermes plc
$0
88.8K sh
Own New
-
Grant·A
VP, Finance (Interim PAO) · 10b5-1
$0
14.2K sh
Own New
-
Grant·A
VP, Finance (Interim PAO) · 10b5-1
$0
15.0K sh
Own New
-
Sell·S
VP, Finance (Interim PAO) · 10b5-1
$201.8K
6.9K sh · $29.29
Own -47%
-
Grant·A
SVP, Chief Commercial Officer · 10b5-1
$0
30.9K sh
Own New
-
Grant·A
SVP, Chief Commercial Officer · 10b5-1
$0
66.4K sh
Own New
-
Sell·S
SVP, Chief Commercial Officer · 10b5-1
$180.0K
6.0K sh · $30.00
Own -5%
-
Grant·A
EVP, Chief Operating Officer
$0
44.1K sh
Own New
-
Grant·A
EVP, Chief Operating Officer
$0
94.9K sh
Own New
-
Grant·A
EVP R&D, Chief Medical Officer · 10b5-1
$0
38.6K sh
Own New
-
Grant·A
EVP R&D, Chief Medical Officer · 10b5-1
$0
83.0K sh
Own New
-
Exercise·M
EVP R&D, Chief Medical Officer · 10b5-1
$0
5.0K sh
Own +31%
-
Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$267.5K
9.0K sh · $29.72
Own -9%
-
Exercise·M
EVP R&D, Chief Medical Officer · 10b5-1
$96.7K
5.0K sh · $19.34
Own +5%
-
Grant·A
EVP, CLO, Alkermes, Inc. · 10b5-1
$0
36.4K sh
Own New
-
Grant·A
EVP, CLO, Alkermes, Inc. · 10b5-1
$0
78.3K sh
Own New
-
Sell·S
EVP, CLO, Alkermes, Inc. · 10b5-1
$59.6K
2.0K sh · $29.29
Own -1%
-
Exercise·M
VP, Finance (Interim PAO)
—
2.7K sh
Own +100%
-
Other·F
VP, Finance (Interim PAO)
$24.8K
808 sh · $30.73
Own -5%
-
Exercise·M
VP, Finance (Interim PAO)
—
2.7K sh
Own +22%
-
Exercise·M
SVP, Chief Commercial Officer
—
5.4K sh
Own +100%
-
Other·F
SVP, Chief Commercial Officer
$73.8K
2.4K sh · $30.73
Own -2%
-
Exercise·M
SVP, Chief Commercial Officer
—
5.4K sh
Own +5%
-
Exercise·M
EVP, Chief Operating Officer
—
8.3K sh
Own +100%
-
Other·F
EVP, Chief Operating Officer
$113.5K
3.7K sh · $30.73
Own -2%
-
Exercise·M
EVP, Chief Operating Officer
—
8.3K sh
Own +4%
-
Exercise·M
EVP R&D, Chief Medical Officer
—
6.9K sh
Own +100%
-
Other·F
EVP R&D, Chief Medical Officer
$93.7K
3.0K sh · $30.73
Own -3%
-
Exercise·M
EVP R&D, Chief Medical Officer
—
6.9K sh
Own +8%
-
Exercise·M
EVP, CLO, Alkermes, Inc.
—
6.9K sh
Own +100%
-
Other·F
EVP, CLO, Alkermes, Inc.
$93.7K
3.0K sh · $30.73
Own -1%
-
Exercise·M
EVP, CLO, Alkermes, Inc.
—
6.9K sh
Own +3%
-
Exercise·M
VP, Finance (Interim PAO)
—
2.3K sh
Own +228300%
-
Other·F
VP, Finance (Interim PAO)
$21.6K
672 sh · $32.19
Own -5%
-
Exercise·M
VP, Finance (Interim PAO)
—
2.3K sh
Own +21%
-
Exercise·M
SVP, Chief Commercial Officer
—
6.4K sh
Own +640700%
-
Other·F
SVP, Chief Commercial Officer
$91.6K
2.8K sh · $32.19
Own -2%
-
Exercise·M
SVP, Chief Commercial Officer
—
6.4K sh
Own +6%
-
Exercise·M
EVP, Chief Operating Officer
—
8.7K sh
Own New
-
Other·F
EVP, Chief Operating Officer
$124.9K
3.9K sh · $32.19
Own -2%
-
Exercise·M
EVP, Chief Operating Officer
—
8.7K sh
Own +4%
-
Exercise·M
EVP R&D, Chief Medical Officer
—
7.7K sh
Own +768900%
-
Other·F
EVP R&D, Chief Medical Officer
$109.9K
3.4K sh · $32.19
Own -4%
-
Exercise·M
EVP R&D, Chief Medical Officer
—
7.7K sh
Own +9%
-
Exercise·M
EVP, CLO, Alkermes, Inc.
—
7.7K sh
Own +768900%
-
Other·F
EVP, CLO, Alkermes, Inc.
$109.9K
3.4K sh · $32.19
Own -1%
-
Exercise·M
EVP, CLO, Alkermes, Inc.
—
7.7K sh
Own +3%
-
Exercise·M
VP, Finance (Interim PAO)
—
3.0K sh
Own +50%
-
Other·F
VP, Finance (Interim PAO)
$31.3K
979 sh · $32.00
Own -8%
-
Exercise·M
VP, Finance (Interim PAO)
—
3.0K sh
Own +33%
-
Exercise·M
SVP, Chief Commercial Officer
—
6.0K sh
Own +50%
-
Other·F
SVP, Chief Commercial Officer
$72.9K
2.3K sh · $32.00
Own -2%
-
Exercise·M
SVP, Chief Commercial Officer
—
6.0K sh
Own +6%
-
Exercise·M
EVP, Chief Operating Officer
—
9.3K sh
Own +50%
-
Other·F
EVP, Chief Operating Officer
$132.2K
4.1K sh · $32.00
Own -2%
-
Exercise·M
EVP, Chief Operating Officer
—
9.3K sh
Own +4%
-
Exercise·M
EVP R&D, Chief Medical Officer
—
7.7K sh
Own +50%
-
Other·F
EVP R&D, Chief Medical Officer
$109.0K
3.4K sh · $32.00
Own -4%
-
Exercise·M
EVP R&D, Chief Medical Officer
—
7.7K sh
Own +9%
-
Exercise·M
EVP, CLO, Alkermes, Inc.
—
7.7K sh
Own +50%
-
Other·F
EVP, CLO, Alkermes, Inc.
$109.0K
3.4K sh · $32.00
Own -1%
-
Exercise·M
EVP, CLO, Alkermes, Inc.
—
7.7K sh
Own +3%
-
Exercise·M
VP, Finance (Interim PAO)
—
2.0K sh
Own New
-
Other·F
VP, Finance (Interim PAO)
$22.6K
706 sh · $32.02
Own -7%
-
Exercise·M
VP, Finance (Interim PAO)
—
2.0K sh
Own +26%
-
Exercise·M
SVP, Chief Commercial Officer
—
6.4K sh
Own New
-
Other·F
SVP, Chief Commercial Officer
$59.8K
1.9K sh · $32.02
Own -2%
-
Exercise·M
SVP, Chief Commercial Officer
—
6.4K sh
Own +6%
-
Exercise·M
EVP, Chief Operating Officer
—
8.9K sh
Own New
-
Other·F
EVP, Chief Operating Officer
$121.5K
3.8K sh · $32.02
Own -2%
-
Exercise·M
EVP, Chief Operating Officer
—
8.9K sh
Own +4%
-
Exercise·M
EVP R&D, Chief Medical Officer
—
8.9K sh
Own New
-
Other·F
EVP R&D, Chief Medical Officer
$112.2K
3.5K sh · $32.02
Own -4%
-
Exercise·M
EVP R&D, Chief Medical Officer
—
8.9K sh
Own +12%
-
Exercise·M
EVP, CLO, Alkermes, Inc.
—
6.4K sh
Own New
-
Other·F
EVP, CLO, Alkermes, Inc.
$68.1K
2.1K sh · $32.02
Own -1%
-
Exercise·M
EVP, CLO, Alkermes, Inc.
—
6.4K sh
Own +3%
-
Other·F
POPS RICHARD F KEY
Director and CEO, Alkermes plc
$2.1M
62.2K sh · $33.55
Own -4%
-
Grant·A
POPS RICHARD F KEY
Director and CEO, Alkermes plc
—
149.6K sh
Own +12%
-
Other·F
SVP, Chief Commercial Officer
$214.4K
6.4K sh · $33.55
Own -6%
-
Grant·A
SVP, Chief Commercial Officer
—
21.1K sh
Own +25%
-
Other·F
EVP, Chief Operating Officer
$289.4K
8.6K sh · $33.55
Own -4%
-
Grant·A
EVP, Chief Operating Officer
—
28.8K sh
Own +14%
-
Other·F
EVP R&D, Chief Medical Officer
$250.1K
7.5K sh · $33.55
Own -9%
-
Grant·A
EVP R&D, Chief Medical Officer
—
25.4K sh
Own +44%
-
Other·F
EVP, CLO, Alkermes, Inc.
$255.6K
7.6K sh · $33.55
Own -3%
-
Grant·A
EVP, CLO, Alkermes, Inc.
—
25.4K sh
Own +12%
-
Exercise·M
EVP R&D, Chief Medical Officer · 10b5-1
$0
5.0K sh
Own +23%
-
Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$134.2K
4.0K sh · $33.54
Own -6%
-
Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$171.2K
5.0K sh · $34.24
Own -7%
-
Exercise·M
EVP R&D, Chief Medical Officer · 10b5-1
$96.7K
5.0K sh · $19.34
Own +8%
-
Exercise·M
Director · 10b5-1
$0
61.2K sh
Own New
-
Sell·S
Director · 10b5-1
$1.1M
32.1K sh · $34.78
Own -24%
-
Sell·S
Director · 10b5-1
$998.8K
29.1K sh · $34.34
Own -18%
-
Exercise·M
Director · 10b5-1
$1.9M
61.2K sh · $31.64
Own +59%
-
Exercise·M
EVP R&D, Chief Medical Officer · 10b5-1
$0
5.0K sh
Own +19%
-
Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$150.0K
5.0K sh · $30.00
Own -7%
-
Exercise·M
EVP R&D, Chief Medical Officer · 10b5-1
$96.7K
5.0K sh · $19.34
Own +8%
-
Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$112.0K
4.0K sh · $28.00
Own -6%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Christopher I Wright 10b5-1 | Sell S | 2.0K | $90.2K |
| Jun 4, 2026 | David Joseph Gaffin 10b5-1 | Sell S | 2.0K | $87.6K |
| Jun 1, 2026 | Craig C. Hopkinson 10b5-1 | Exercise M | 5.0K | $0 |
| Jun 1, 2026 | Craig C. Hopkinson 10b5-1 | Sell S | 9.0K | $375.0K |
| Jun 1, 2026 | Craig C. Hopkinson 10b5-1 | Exercise M | 5.0K | $96.7K |
| May 29, 2026 | Samuel Joseph Parisi | Exercise M | 12.8K | $0 |
| May 29, 2026 | Samuel Joseph Parisi | Exercise M | 3.4K | $0 |
| May 29, 2026 | Samuel Joseph Parisi | Sell S | 16.2K | $687.0K |
| May 29, 2026 | Samuel Joseph Parisi | Exercise M | 12.8K | $248.0K |
| May 29, 2026 | Samuel Joseph Parisi | Exercise M | 3.4K | $67.9K |
| May 21, 2026 | Christopher I Wright | Exercise M | 6.1K | — |
| May 21, 2026 | Christopher I Wright | Other F | 1.5K | $54.5K |
| May 21, 2026 | Christopher I Wright | Exercise M | 6.1K | — |
| May 21, 2026 | Frank Anders Wilson | Exercise M | 6.1K | — |
| May 21, 2026 | Frank Anders Wilson | Other F | 1.5K | $54.5K |
| May 21, 2026 | Frank Anders Wilson | Exercise M | 6.1K | — |
| May 21, 2026 | Nancy Lynn Snyderman MD | Exercise M | 6.1K | — |
| May 21, 2026 | Nancy Lynn Snyderman MD | Other F | 1.5K | $54.5K |
| May 21, 2026 | Nancy Lynn Snyderman MD | Exercise M | 6.1K | — |
| May 21, 2026 | Brian P Mckeon | Exercise M | 6.1K | — |
| May 21, 2026 | Brian P Mckeon | Other F | 1.5K | $54.5K |
| May 21, 2026 | Brian P Mckeon | Exercise M | 6.1K | — |
| May 21, 2026 | Nancy Lurker | Exercise M | 6.1K | — |
| May 21, 2026 | Nancy Lurker | Other F | 1.5K | $54.5K |
| May 21, 2026 | Nancy Lurker | Exercise M | 6.1K | — |
| May 21, 2026 | Cato T Laurencin | Exercise M | 6.1K | — |
| May 21, 2026 | Cato T Laurencin | Other F | 1.5K | $54.5K |
| May 21, 2026 | Cato T Laurencin | Exercise M | 6.1K | — |
| May 21, 2026 | Richard Gaynor | Exercise M | 6.1K | — |
| May 21, 2026 | Richard Gaynor | Other F | 1.5K | $54.5K |
| May 21, 2026 | Richard Gaynor | Exercise M | 6.1K | — |
| May 21, 2026 | Shane Cooke | Exercise M | 6.1K | — |
| May 21, 2026 | Shane Cooke | Other F | 3.2K | $118.5K |
| May 21, 2026 | Shane Cooke | Exercise M | 6.1K | — |
| May 20, 2026 | Richard Gaynor | Grant A | 5.4K | $0 |
| May 20, 2026 | Richard Gaynor | Grant A | 11.5K | $0 |
| May 20, 2026 | Shane Cooke | Grant A | 5.4K | $0 |
| May 20, 2026 | Shane Cooke | Grant A | 11.5K | $0 |
| May 20, 2026 | Christopher I Wright | Grant A | 5.4K | $0 |
| May 20, 2026 | Christopher I Wright | Grant A | 11.5K | $0 |
| May 20, 2026 | Frank Anders Wilson | Grant A | 5.4K | $0 |
| May 20, 2026 | Frank Anders Wilson | Grant A | 11.5K | $0 |
| May 20, 2026 | Nancy Lynn Snyderman MD | Grant A | 5.4K | $0 |
| May 20, 2026 | Nancy Lynn Snyderman MD | Grant A | 11.5K | $0 |
| May 20, 2026 | Brian P Mckeon | Grant A | 5.4K | $0 |
| May 20, 2026 | Brian P Mckeon | Grant A | 11.5K | $0 |
| May 20, 2026 | Nancy Lurker | Grant A | 5.4K | $0 |
| May 20, 2026 | Nancy Lurker | Grant A | 11.5K | $0 |
| May 20, 2026 | Cato T Laurencin | Grant A | 5.4K | $0 |
| May 20, 2026 | Cato T Laurencin | Grant A | 11.5K | $0 |
| May 20, 2026 | Richard Gaynor | Grant A | 5.4K | $0 |
| May 20, 2026 | Richard Gaynor | Grant A | 11.5K | $0 |
| May 20, 2026 | Shane Cooke | Grant A | 5.4K | $0 |
| May 20, 2026 | Shane Cooke | Grant A | 11.5K | $0 |
| May 4, 2026 | David Joseph Gaffin 10b5-1 | Sell S | 2.0K | $67.5K |
| May 1, 2026 | Craig C. Hopkinson 10b5-1 | Exercise M | 5.0K | $0 |
| May 1, 2026 | Craig C. Hopkinson 10b5-1 | Sell S | 9.0K | $300.6K |
| May 1, 2026 | Craig C. Hopkinson 10b5-1 | Exercise M | 5.0K | $96.7K |
| Apr 11, 2026 | Nancy Lurker | Exercise M | 3.8K | — |
| Apr 11, 2026 | Nancy Lurker | Other F | 901 | $30.1K |
| Apr 11, 2026 | Nancy Lurker | Exercise M | 3.8K | — |
| Apr 6, 2026 | David Joseph Gaffin 10b5-1 | Sell S | 2.0K | $70.3K |
| Apr 1, 2026 | Craig C. Hopkinson 10b5-1 | Exercise M | 5.0K | $0 |
| Apr 1, 2026 | Craig C. Hopkinson 10b5-1 | Sell S | 9.0K | $319.6K |
| Apr 1, 2026 | Craig C. Hopkinson 10b5-1 | Exercise M | 5.0K | $96.7K |
| Mar 3, 2026 | David Joseph Gaffin 10b5-1 | Sell S | 2.0K | $60.5K |
| Mar 2, 2026 | Joshua Reed KEY | Grant A | 30.9K | $0 |
| Mar 2, 2026 | Joshua Reed KEY | Grant A | 66.4K | $0 |
| Mar 2, 2026 | POPS RICHARD F KEY | Grant A | 88.8K | $0 |
| Mar 2, 2026 | Samuel Joseph Parisi 10b5-1 | Grant A | 14.2K | $0 |
| Mar 2, 2026 | Samuel Joseph Parisi 10b5-1 | Grant A | 15.0K | $0 |
| Mar 2, 2026 | Samuel Joseph Parisi 10b5-1 | Sell S | 6.9K | $201.8K |
| Mar 2, 2026 | Christian Todd Nichols 10b5-1 | Grant A | 30.9K | $0 |
| Mar 2, 2026 | Christian Todd Nichols 10b5-1 | Grant A | 66.4K | $0 |
| Mar 2, 2026 | Christian Todd Nichols 10b5-1 | Sell S | 6.0K | $180.0K |
| Mar 2, 2026 | Blair Curtis Jackson | Grant A | 44.1K | $0 |
| Mar 2, 2026 | Blair Curtis Jackson | Grant A | 94.9K | $0 |
| Mar 2, 2026 | Craig C. Hopkinson 10b5-1 | Grant A | 38.6K | $0 |
| Mar 2, 2026 | Craig C. Hopkinson 10b5-1 | Grant A | 83.0K | $0 |
| Mar 2, 2026 | Craig C. Hopkinson 10b5-1 | Exercise M | 5.0K | $0 |
| Mar 2, 2026 | Craig C. Hopkinson 10b5-1 | Sell S | 9.0K | $267.5K |
| Mar 2, 2026 | Craig C. Hopkinson 10b5-1 | Exercise M | 5.0K | $96.7K |
| Mar 2, 2026 | David Joseph Gaffin 10b5-1 | Grant A | 36.4K | $0 |
| Mar 2, 2026 | David Joseph Gaffin 10b5-1 | Grant A | 78.3K | $0 |
| Mar 2, 2026 | David Joseph Gaffin 10b5-1 | Sell S | 2.0K | $59.6K |
| Feb 26, 2026 | Samuel Joseph Parisi | Exercise M | 2.7K | — |
| Feb 26, 2026 | Samuel Joseph Parisi | Other F | 808 | $24.8K |
| Feb 26, 2026 | Samuel Joseph Parisi | Exercise M | 2.7K | — |
| Feb 26, 2026 | Christian Todd Nichols | Exercise M | 5.4K | — |
| Feb 26, 2026 | Christian Todd Nichols | Other F | 2.4K | $73.8K |
| Feb 26, 2026 | Christian Todd Nichols | Exercise M | 5.4K | — |
| Feb 26, 2026 | Blair Curtis Jackson | Exercise M | 8.3K | — |
| Feb 26, 2026 | Blair Curtis Jackson | Other F | 3.7K | $113.5K |
| Feb 26, 2026 | Blair Curtis Jackson | Exercise M | 8.3K | — |
| Feb 26, 2026 | Craig C. Hopkinson | Exercise M | 6.9K | — |
| Feb 26, 2026 | Craig C. Hopkinson | Other F | 3.0K | $93.7K |
| Feb 26, 2026 | Craig C. Hopkinson | Exercise M | 6.9K | — |
| Feb 26, 2026 | David Joseph Gaffin | Exercise M | 6.9K | — |
| Feb 26, 2026 | David Joseph Gaffin | Other F | 3.0K | $93.7K |
| Feb 26, 2026 | David Joseph Gaffin | Exercise M | 6.9K | — |
| Feb 23, 2026 | Samuel Joseph Parisi | Exercise M | 2.3K | — |
| Feb 23, 2026 | Samuel Joseph Parisi | Other F | 672 | $21.6K |
| Feb 23, 2026 | Samuel Joseph Parisi | Exercise M | 2.3K | — |
| Feb 23, 2026 | Christian Todd Nichols | Exercise M | 6.4K | — |
| Feb 23, 2026 | Christian Todd Nichols | Other F | 2.8K | $91.6K |
| Feb 23, 2026 | Christian Todd Nichols | Exercise M | 6.4K | — |
| Feb 23, 2026 | Blair Curtis Jackson | Exercise M | 8.7K | — |
| Feb 23, 2026 | Blair Curtis Jackson | Other F | 3.9K | $124.9K |
| Feb 23, 2026 | Blair Curtis Jackson | Exercise M | 8.7K | — |
| Feb 23, 2026 | Craig C. Hopkinson | Exercise M | 7.7K | — |
| Feb 23, 2026 | Craig C. Hopkinson | Other F | 3.4K | $109.9K |
| Feb 23, 2026 | Craig C. Hopkinson | Exercise M | 7.7K | — |
| Feb 23, 2026 | David Joseph Gaffin | Exercise M | 7.7K | — |
| Feb 23, 2026 | David Joseph Gaffin | Other F | 3.4K | $109.9K |
| Feb 23, 2026 | David Joseph Gaffin | Exercise M | 7.7K | — |
| Feb 19, 2026 | Samuel Joseph Parisi | Exercise M | 3.0K | — |
| Feb 19, 2026 | Samuel Joseph Parisi | Other F | 979 | $31.3K |
| Feb 19, 2026 | Samuel Joseph Parisi | Exercise M | 3.0K | — |
| Feb 19, 2026 | Christian Todd Nichols | Exercise M | 6.0K | — |
| Feb 19, 2026 | Christian Todd Nichols | Other F | 2.3K | $72.9K |
| Feb 19, 2026 | Christian Todd Nichols | Exercise M | 6.0K | — |
| Feb 19, 2026 | Blair Curtis Jackson | Exercise M | 9.3K | — |
| Feb 19, 2026 | Blair Curtis Jackson | Other F | 4.1K | $132.2K |
| Feb 19, 2026 | Blair Curtis Jackson | Exercise M | 9.3K | — |
| Feb 19, 2026 | Craig C. Hopkinson | Exercise M | 7.7K | — |
| Feb 19, 2026 | Craig C. Hopkinson | Other F | 3.4K | $109.0K |
| Feb 19, 2026 | Craig C. Hopkinson | Exercise M | 7.7K | — |
| Feb 19, 2026 | David Joseph Gaffin | Exercise M | 7.7K | — |
| Feb 19, 2026 | David Joseph Gaffin | Other F | 3.4K | $109.0K |
| Feb 19, 2026 | David Joseph Gaffin | Exercise M | 7.7K | — |
| Feb 18, 2026 | Samuel Joseph Parisi | Exercise M | 2.0K | — |
| Feb 18, 2026 | Samuel Joseph Parisi | Other F | 706 | $22.6K |
| Feb 18, 2026 | Samuel Joseph Parisi | Exercise M | 2.0K | — |
| Feb 18, 2026 | Christian Todd Nichols | Exercise M | 6.4K | — |
| Feb 18, 2026 | Christian Todd Nichols | Other F | 1.9K | $59.8K |
| Feb 18, 2026 | Christian Todd Nichols | Exercise M | 6.4K | — |
| Feb 18, 2026 | Blair Curtis Jackson | Exercise M | 8.9K | — |
| Feb 18, 2026 | Blair Curtis Jackson | Other F | 3.8K | $121.5K |
| Feb 18, 2026 | Blair Curtis Jackson | Exercise M | 8.9K | — |
| Feb 18, 2026 | Craig C. Hopkinson | Exercise M | 8.9K | — |
| Feb 18, 2026 | Craig C. Hopkinson | Other F | 3.5K | $112.2K |
| Feb 18, 2026 | Craig C. Hopkinson | Exercise M | 8.9K | — |
| Feb 18, 2026 | David Joseph Gaffin | Exercise M | 6.4K | — |
| Feb 18, 2026 | David Joseph Gaffin | Other F | 2.1K | $68.1K |
| Feb 18, 2026 | David Joseph Gaffin | Exercise M | 6.4K | — |
| Feb 5, 2026 | POPS RICHARD F KEY | Other F | 62.2K | $2.1M |
| Feb 5, 2026 | POPS RICHARD F KEY | Grant A | 149.6K | — |
| Feb 5, 2026 | Christian Todd Nichols | Other F | 6.4K | $214.4K |
| Feb 5, 2026 | Christian Todd Nichols | Grant A | 21.1K | — |
| Feb 5, 2026 | Blair Curtis Jackson | Other F | 8.6K | $289.4K |
| Feb 5, 2026 | Blair Curtis Jackson | Grant A | 28.8K | — |
| Feb 5, 2026 | Craig C. Hopkinson | Other F | 7.5K | $250.1K |
| Feb 5, 2026 | Craig C. Hopkinson | Grant A | 25.4K | — |
| Feb 5, 2026 | David Joseph Gaffin | Other F | 7.6K | $255.6K |
| Feb 5, 2026 | David Joseph Gaffin | Grant A | 25.4K | — |
| Feb 2, 2026 | Craig C. Hopkinson 10b5-1 | Exercise M | 5.0K | $0 |
| Feb 2, 2026 | Craig C. Hopkinson 10b5-1 | Sell S | 4.0K | $134.2K |
| Feb 2, 2026 | Craig C. Hopkinson 10b5-1 | Sell S | 5.0K | $171.2K |
| Feb 2, 2026 | Craig C. Hopkinson 10b5-1 | Exercise M | 5.0K | $96.7K |
| Feb 2, 2026 | Shane Cooke 10b5-1 | Exercise M | 61.2K | $0 |
| Feb 2, 2026 | Shane Cooke 10b5-1 | Sell S | 32.1K | $1.1M |
| Feb 2, 2026 | Shane Cooke 10b5-1 | Sell S | 29.1K | $998.8K |
| Feb 2, 2026 | Shane Cooke 10b5-1 | Exercise M | 61.2K | $1.9M |
| Jan 8, 2026 | Craig C. Hopkinson 10b5-1 | Exercise M | 5.0K | $0 |
| Jan 8, 2026 | Craig C. Hopkinson 10b5-1 | Sell S | 5.0K | $150.0K |
| Jan 8, 2026 | Craig C. Hopkinson 10b5-1 | Exercise M | 5.0K | $96.7K |
| Jan 2, 2026 | Craig C. Hopkinson 10b5-1 | Sell S | 4.0K | $112.0K |
About ALKS insider trading
This page tracks insider transactions for Alkermes plc. (ALKS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.